《新股表現》力天影業(09958.HK)低開近6.3%報2.4元
力天影業(09958.HK)暗盤曾升27%高見3.25元無以為繼,掉頭曾倒跌14%低見2.2元獲承接,平收2.56元;該股首掛開報2.4元,較上市價2.56元,低6.3%,市前成交494萬股。
力天為內地電視劇發行商。是次來港上市共發售7,500萬股,其中10%公開發售獲近11倍超購,認購一手中籤率20%,股份以招股範圍(2.56-3.84元)下限定價,料集資淨額約1.41億元,主要用作電視劇製作、向第三方版權擁有人/許可方買斷有關電視劇版權或播映權,以及僱用員工等。上市獨家保薦人方正證券。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.